The FirstTake Podcast – A landmark CAR-T approval in multiple myeloma

FirstTake on Pharma - Pharma News and Analysis Podcast

English - April 01, 2021 19:00 - 22 minutes - 15.1 MB - ★★★★★ - 2 ratings
Science pharma pharmaceutical intelligence firstword firsttake cardiovascular dermatology diabetes immunology infectious diseases Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: The FirstTake Podcast – Another rollercoaster week for AstraZeneca’s COVID-19 vaccine

Next Episode: The FirstTake Podcast – Two US biotechs run into trouble at the FDA

FirstWord Pharma PLUS editor Simon King discusses the approval of Bristol Myers Squibb and bluebird bio’s CAR-T therapy Abecma for multiple myeloma with senior Therapy Trends analyst Sarah Harris, speaks to Novartis’ European gene therapy chief Mike Fraser about the launch of Zolgensma and asks FirstWord HealthTech's Tina Tan why the US Federal Trade Commission is looking to block Illumina’s proposed acquisition of Grail in the cancer diagnostics market.